Salivary amyloid β42 levels in mild cognitive impairment among aged diabetics

Aim The aim of this study was to explore the link between salivary amyloid β42 level (as a surrogate marker for Alzheimer’s disease pathology) and mild cognitive impairment among old diabetic patients.